Skip to main content
VCbacked
Log inGet Started

Hopewell Therapeutics

Woburn, United States

Hopewell Therapeutics is a Synthetic Lipid-based drug delivery company for gene therapy and gene editing.

$2.5M raised
Sep 2025
Venture - Series Unknown
BiotechnologyHealth CareLife Science

Top Investors

5Y CapitalBOPUIMO VenturesHike CapitalWS Investment Company

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Hopewell Therapeutics

How much funding has Hopewell Therapeutics raised?
Hopewell Therapeutics has raised $2.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2025.
Who are Hopewell Therapeutics's investors?
Hopewell Therapeutics's investors include 5Y Capital, BOPU, IMO Ventures, Hike Capital, WS Investment Company.
Where is Hopewell Therapeutics headquartered?
Hopewell Therapeutics is headquartered in Woburn, United States.
What does Hopewell Therapeutics do?
Hopewell Therapeutics is a Synthetic Lipid-based drug delivery company for gene therapy and gene editing.
What stage is Hopewell Therapeutics at?
Hopewell Therapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Hopewell Therapeutics — Funding & Investors." VCBacked, September 16, 2025, https://www.vcbacked.co/company/hopewell-therapeutics. Accessed June 7, 2026.
APA
VCBacked. (2025). Hopewell Therapeutics — Funding & Investors. Retrieved June 7, 2026, from https://www.vcbacked.co/company/hopewell-therapeutics
Wikipedia (cite web)
{{cite web |title=Hopewell Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/hopewell-therapeutics |website=VCBacked |access-date=June 7, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong